Cardiff Oncology, Inc.
CRDF
$1.05
-$0.05-4.55%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -9.23M | -12.35M | -7.22M | -11.26M | -13.94M |
| Total Depreciation and Amortization | 222.00K | 221.00K | 223.00K | 224.00K | 229.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 856.00K | 1.57M | 1.10M | 1.13M | 1.38M |
| Change in Net Operating Assets | -3.61M | -1.73M | -77.00K | -932.00K | 4.00M |
| Cash from Operations | -11.77M | -12.29M | -5.97M | -10.83M | -8.33M |
| Capital Expenditure | -44.00K | -- | 0.00 | -18.00K | -26.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 12.31M | 3.26M | 10.75M | 10.18M | -4.96M |
| Cash from Investing | 12.27M | 3.26M | 10.75M | 10.16M | -4.98M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 213.00K | 105.00K | 2.55M | 25.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -64.00K | -- | -- | -- | -- |
| Cash from Financing | 149.00K | 105.00K | 2.55M | 25.00K | 0.00 |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 653.00K | -8.93M | 7.34M | -649.00K | -13.31M |